PL1633771T3 - Koniugaty makrolidowe o aktywności przeciwzapalnej - Google Patents

Koniugaty makrolidowe o aktywności przeciwzapalnej

Info

Publication number: PL1633771T3
Authority: PL; Poland
Prior art keywords: macrolide; conjugates; inflammatory activity; inflammatory; activity
Prior art date: 2003-04-24

Application number

PL04729157T

Other languages

English (en)

Inventor

Mladen Mercep

Milan Mesic

Linda Tomaskovic

Stribor Markovic

Boska Hrvacic

Oresta Makaruha

Visnja Poljak

Original Assignee

Glaxosmithkline Istrazivacki Centar Zagreb D O O

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-24

Filing date

2004-04-23

Publication date

2009-12-31

2004-04-23 Application filed by Glaxosmithkline Istrazivacki Centar Zagreb D O O filed Critical Glaxosmithkline Istrazivacki Centar Zagreb D O O

2009-12-31 Publication of PL1633771T3 publication Critical patent/PL1633771T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Genetics & Genomics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Biotechnology (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Communicable Diseases (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Plural Heterocyclic Compounds (AREA)

PL04729157T 2003-04-24 2004-04-23 Koniugaty makrolidowe o aktywności przeciwzapalnej PL1633771T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
HR20030324A HRP20030324A2 (en)	2003-04-24	2003-04-24	Compounds of antiinflammatory effect
PCT/IB2004/001235 WO2004094449A1 (en)	2003-04-24	2004-04-23	Macrolide-conjugates with anti-inflammatory activity
EP04729157A EP1633771B1 (en)	2003-04-24	2004-04-23	Macrolide-conjugates with anti-inflammatory activity

Publications (1)

Publication Number	Publication Date
PL1633771T3 true PL1633771T3 (pl)	2009-12-31

Family

ID=33307078

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL04729157T PL1633771T3 (pl)	2003-04-24	2004-04-23	Koniugaty makrolidowe o aktywności przeciwzapalnej
PL09075145T PL2070940T3 (pl)	2003-04-24	2004-04-23	Makrolidowe koniugaty o aktywności przeciwzapalnej

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL09075145T PL2070940T3 (pl)	2003-04-24	2004-04-23	Makrolidowe koniugaty o aktywności przeciwzapalnej

Country Status (27)

Country	Link
US (1)	US7579334B2 (pl)
EP (2)	EP2070940B1 (pl)
JP (1)	JP4613366B2 (pl)
KR (1)	KR101107336B1 (pl)
CN (1)	CN100393741C (pl)
AR (1)	AR044083A1 (pl)
AT (1)	ATE518876T1 (pl)
AU (1)	AU2004232546B2 (pl)
BR (1)	BRPI0410490A (pl)
CA (1)	CA2523081C (pl)
CL (1)	CL2004000872A1 (pl)
CY (2)	CY1109491T1 (pl)
DE (1)	DE602004022047D1 (pl)
DK (2)	DK1633771T3 (pl)
ES (2)	ES2370371T3 (pl)
HR (3)	HRP20030324A2 (pl)
IS (2)	IS2736B (pl)
ME (1)	MEP34708A (pl)
MX (1)	MXPA05011359A (pl)
NO (2)	NO333909B1 (pl)
PL (2)	PL1633771T3 (pl)
PT (2)	PT2070940E (pl)
RS (1)	RS52621B (pl)
RU (1)	RU2355699C2 (pl)
SI (2)	SI1633771T1 (pl)
WO (1)	WO2004094449A1 (pl)
ZA (1)	ZA200508388B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR043050A1 (es)	2002-09-26	2005-07-13	Rib X Pharmaceuticals Inc	Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
HRP20030324A2 (en)	2003-04-24	2005-02-28	Pliva-Istra�iva�ki institut d.o.o.	Compounds of antiinflammatory effect
JP5383037B2 (ja)	2004-02-27	2014-01-08	リブ−エックスファーマシューティカルズ，インコーポレイテッド	大環状化合物およびそれらを製造し使用する方法
US20060183696A1 (en) *	2004-08-12	2006-08-17	Pliva-Istrazivacki Institut D.O.O.	Use of immune cell specific conjugates for treatment of inflammatory diseases of gastrointestinal tract
JP2008509899A (ja) *	2004-08-12	2008-04-03	グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ	胃腸管の炎症性疾患治療用の細胞特異的コンジュゲートの使用
WO2006046123A2 (en) *	2004-10-27	2006-05-04	Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.	Conjugates with anti-inflammatory activity
WO2007073505A2 (en) *	2005-12-22	2007-06-28	Hydra Biosciences, Inc.	Trpa1 inhibitors for treating pain
WO2007093840A2 (en) *	2006-02-15	2007-08-23	Glaxosmithkline Istrazivacki Centar Zagreb D.O.O.	Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract
AU2009220779A1 (en) *	2008-03-05	2009-09-11	Panacea Biotec Limited	Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
CN102838660B (zh) *	2011-06-23	2016-11-02	上海市第一人民医院	一种抑制炎症免疫反应的小肽及其应用
JP2016505038A (ja) *	2013-01-23	2016-02-18	スファエラファーマプライベートリミテッド	ミトコンドリア生合成ならびにミトコンドリア機能不全または欠乏に関連する疾患において使用するための１１β−ヒドロキシステロイドの新規の化合物
WO2014138437A1 (en)	2013-03-08	2014-09-12	Allergan, Inc.	Steroid conjugates
US20140256666A1 (en) *	2013-03-08	2014-09-11	Allergan, Inc.	Antibiotic conjugates with nonsteroidal anti-inflammatory drugs
EP2964266A1 (en)	2013-03-08	2016-01-13	Allergan, Inc.	Antibiotic conjugates directly linked with steroid drugs
CA2903438A1 (en) *	2013-03-08	2014-09-12	Allergan, Inc.	Antibiotic conjugates linked with steroid drugs
CN106714770B (zh)	2014-07-23	2024-04-19	斯法尔制药私人有限公司	羟基类固醇化合物、其中间体、制备方法、组合物及其用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3779221D1 (de)	1986-08-19	1992-06-25	Genentech Inc	Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und -zytokinen.
EP0283055B1 (en)	1987-09-03	1990-08-29	SOUR PLIVA farmaceutska, Kemijska prehrambena i kozmeticka industrija, n.sol.o.	10-dihydro-10-deoxo-11-azaerythronolide-a-compounds, methods and intermediates for the manufacture thereof and their use in pharmaceuticals and in the manufacture thereof
SE9100342D0 (sv)	1991-02-04	1991-02-04	Astra Ab	Novel steroid esters
SE9100341D0 (sv)	1991-02-04	1991-02-04	Astra Ab	Novel steroids
GB9225923D0 (en)	1992-12-11	1993-02-03	Rhone Poulenc Rorer Ltd	New compositions of matter
PL309402A1 (en)	1992-12-24	1995-10-02	Rhone Poulenc Rorer Ltd	Novel steroides
CA2196878A1 (en)	1994-08-12	1996-02-22	Akihiko Hoshino	Interleukin-5 production inhibitor
CA2196879A1 (en)	1994-08-12	1996-02-22	Akihiko Hoshino	Interleukin-5 production inhibitor
DE19616573C2 (de)	1996-04-25	1999-03-04	Pari Gmbh	Verwendung unterkritischer Treibmittelmischungen und Aerosole für die Mikronisierung von Arzneimitteln mit Hilfe dichter Gase
JP3530004B2 (ja)	1998-02-06	2004-05-24	株式会社日立ユニシアオートモティブ	吸入式投薬器
US6297260B1 (en) *	1998-10-30	2001-10-02	Nitromed, Inc.	Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
IT1306205B1 (it)	1999-01-15	2001-05-30	Zambon Spa	Macrolidi ad attivita' antiinfiammatoria.
HRP20000310A2 (en)	2000-05-17	2002-02-28	Pliva Farmaceutska Ind Dioniko	New dibenzoazulene compounds as tumor necrosis factor inhibitors
FI110835B (fi)	2000-07-11	2003-03-31	Radiolinja Ab	Menetelmä palvelunumeropuhelun tarjoamiseksi matkaviestintilaajalle ennalta määrätyllä taksalla
HRP20010018A2 (en)	2001-01-09	2002-12-31	Pliva D D	Novel anti-inflammatory compounds
US20040186063A1 (en) *	2002-02-15	2004-09-23	Hans-Jurgen Gutke	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
WO2003070173A2 (en) *	2002-02-15	2003-08-28	Sympore Gmbh	Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
HRP20040850A2 (en)	2002-02-15	2005-08-31	Synovo Gmbh	Conjugates of biologically active compounds, methods for their preparation and use formulation and pharmaceutical applications thereof
PL374646A1 (pl)	2002-07-08	2005-10-31	Pliva-Istrazivacki Institutt D.O.O.	Nowe niesteroidowe substancje przeciwzapalne orazkompozycje i sposoby ich stosowania
DE60327341D1 (de)	2002-07-08	2009-06-04	Glaxosmithkline Zagreb	Hybridmoleküle von makroliden mit steroidalen/nicht-steroidalen antientzündlich aktiven molekülen
NZ537717A (en) *	2002-07-08	2006-04-28	Pliva Istrazivacki Inst D	New compounds, compositions and methods for treatment of inflammatory diseases and conditions
HRP20030324A2 (en)	2003-04-24	2005-02-28	Pliva-Istra�iva�ki institut d.o.o.	Compounds of antiinflammatory effect

2003
- 2003-04-24 HR HR20030324A patent/HRP20030324A2/hr not_active Application Discontinuation
2004
- 2004-04-22 US US10/830,858 patent/US7579334B2/en not_active Expired - Fee Related
- 2004-04-23 ES ES09075145T patent/ES2370371T3/es not_active Expired - Lifetime
- 2004-04-23 BR BRPI0410490-0A patent/BRPI0410490A/pt not_active Application Discontinuation
- 2004-04-23 RU RU2005131937/04A patent/RU2355699C2/ru not_active IP Right Cessation
- 2004-04-23 PL PL04729157T patent/PL1633771T3/pl unknown
- 2004-04-23 MX MXPA05011359A patent/MXPA05011359A/es active IP Right Grant
- 2004-04-23 CL CL200400872A patent/CL2004000872A1/es unknown
- 2004-04-23 SI SI200431253T patent/SI1633771T1/sl unknown
- 2004-04-23 WO PCT/IB2004/001235 patent/WO2004094449A1/en not_active Ceased
- 2004-04-23 PT PT09075145T patent/PT2070940E/pt unknown
- 2004-04-23 KR KR1020057020252A patent/KR101107336B1/ko not_active Expired - Fee Related
- 2004-04-23 AR ARP040101400A patent/AR044083A1/es unknown
- 2004-04-23 ES ES04729157T patent/ES2330109T3/es not_active Expired - Lifetime
- 2004-04-23 DK DK04729157T patent/DK1633771T3/da active
- 2004-04-23 JP JP2006506511A patent/JP4613366B2/ja not_active Expired - Fee Related
- 2004-04-23 AU AU2004232546A patent/AU2004232546B2/en not_active Ceased
- 2004-04-23 RS YU20050873A patent/RS52621B/sr unknown
- 2004-04-23 EP EP09075145A patent/EP2070940B1/en not_active Expired - Lifetime
- 2004-04-23 EP EP04729157A patent/EP1633771B1/en not_active Expired - Lifetime
- 2004-04-23 SI SI200431768T patent/SI2070940T1/sl unknown
- 2004-04-23 PL PL09075145T patent/PL2070940T3/pl unknown
- 2004-04-23 PT PT04729157T patent/PT1633771E/pt unknown
- 2004-04-23 CA CA2523081A patent/CA2523081C/en not_active Expired - Lifetime
- 2004-04-23 ME MEP-347/08A patent/MEP34708A/xx unknown
- 2004-04-23 AT AT09075145T patent/ATE518876T1/de active
- 2004-04-23 HR HR20090551T patent/HRP20090551T1/hr unknown
- 2004-04-23 DE DE602004022047T patent/DE602004022047D1/de not_active Expired - Lifetime
- 2004-04-23 DK DK09075145.4T patent/DK2070940T3/da active
- 2004-04-23 CN CNB2004800110487A patent/CN100393741C/zh not_active Expired - Fee Related
2005
- 2005-10-17 ZA ZA200508388A patent/ZA200508388B/xx unknown
- 2005-11-22 IS IS8141A patent/IS2736B/is unknown
- 2005-11-23 NO NO20055535A patent/NO333909B1/no not_active IP Right Cessation
2009
- 2009-10-14 CY CY20091101070T patent/CY1109491T1/el unknown
2010
- 2010-12-29 IS IS8941A patent/IS8941A/is unknown
2011
- 2011-10-19 HR HR20110763T patent/HRP20110763T1/hr unknown
- 2011-10-25 CY CY20111101008T patent/CY1111978T1/el unknown
2013
- 2013-06-28 NO NO20130898A patent/NO335552B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
HK1129681A1 (en)	2009-12-04
HRP20030324A2 (en)	2005-02-28
KR101107336B1 (ko)	2012-01-19
DE602004022047D1 (de)	2009-08-27
WO2004094449A8 (en)	2005-03-31
EP2070940A1 (en)	2009-06-17
HK1086842A1 (zh)	2006-09-29
MXPA05011359A (es)	2006-05-12
RU2355699C2 (ru)	2009-05-20
NO335552B1 (no)	2014-12-29
EP2070940B1 (en)	2011-08-03
KR20060024770A (ko)	2006-03-17
AU2004232546B2 (en)	2011-06-09
HRP20090551T1 (hr)	2010-01-31
RS52621B (sr)	2013-06-28
PT1633771E (pt)	2009-10-20
NO20130898L (no)	2006-01-16
IS8941A (is)	2010-12-29
BRPI0410490A (pt)	2006-06-13
ATE518876T1 (de)	2011-08-15
PL2070940T3 (pl)	2011-12-30
RU2005131937A (ru)	2006-06-27
NO333909B1 (no)	2013-10-14
ES2330109T3 (es)	2009-12-04
CA2523081A1 (en)	2004-11-04
EP2070940A3 (en)	2009-11-25
AU2004232546A1 (en)	2004-11-04
CY1111978T1 (el)	2015-11-04
EP1633771A1 (en)	2006-03-15
ES2370371T3 (es)	2011-12-14
NO20055535D0 (no)	2005-11-23
US20050080003A1 (en)	2005-04-14
IS8141A (is)	2005-11-22
CY1109491T1 (el)	2014-08-13
RS20050873A (sr)	2007-08-03
MEP34708A (en)	2011-05-10
SI2070940T1 (sl)	2011-12-30
US7579334B2 (en)	2009-08-25
IS2736B (is)	2011-06-15
AR044083A1 (es)	2005-08-24
PT2070940E (pt)	2011-11-14
EP1633771B1 (en)	2009-07-15
ZA200508388B (en)	2006-07-26
HRP20110763T1 (hr)	2011-11-30
WO2004094449A1 (en)	2004-11-04
JP2006524221A (ja)	2006-10-26
SI1633771T1 (sl)	2009-12-31
CN100393741C (zh)	2008-06-11
CA2523081C (en)	2010-08-03
CL2004000872A1 (es)	2005-03-18
CN1777619A (zh)	2006-05-24
DK2070940T3 (da)	2011-10-31
JP4613366B2 (ja)	2011-01-19
NO20055535L (no)	2006-01-16
DK1633771T3 (da)	2009-11-16

Publication	Publication Date	Title
IL172777A0 (en)	2006-04-10	Specific glucocoticosteroid compound having anti-inflammatory activity
IS8941A (is)	2010-12-29	Efnasambönd með bólgueyðandi virkni
IL176358A0 (en)	2006-10-05	3-cyano-quinoline derivatives with antiproliferative activity
PL377236A1 (pl)	2006-01-23	Indazoloamidy wykazujące działanie przeciwbólowe
IL175857A0 (en)	2008-02-09	Anti-inflammatory agents
TW547546U (en)	2003-08-11	Axis structure
GB0327775D0 (en)	2003-12-31	Anti-inflammatory agents
AU2003224677A8 (en)	2003-09-29	Aza-benzothiopyranoindazoles with antitumor activity
AU2003225764A8 (en)	2003-09-29	Aza-thioxanthenones with antitumor activity
GB0318014D0 (en)	2003-09-03	Anti-inflammatory agent
TW575159U (en)	2004-02-01	Diversion structure
MY144310A (en)	2011-08-29	3-cyano-quinoline deriatives with antiproliferative activity
GB0311576D0 (en)	2003-06-25	Anti-inflammatory agents
TW505115U (en)	2002-10-01	Improved hub structure
TW571835U (en)	2004-01-11	Sprayer-nozzle structure
GB0323824D0 (en)	2003-11-12	Structure
GB0220924D0 (en)	2003-07-16	Structure
HU2506U (en)	2003-04-28	Distance-piece- fastener structure
GB0220926D0 (en)	2002-10-23	Structure
TW515465U (en)	2002-12-21	Improved nightstool structure
TW514100U (en)	2002-12-11	Improved lock-ball structure
TW566502U (en)	2003-12-11	Improved free-light structure
TW514101U (en)	2002-12-11	Improved lock-latch structure
GB0417734D0 (en)	2004-09-08	Anti-Inflammatory agents
GB0417436D0 (en)	2004-09-08	Anti-inflammatory agents